Oncology & Cancer

Novel class of drugs may help treat deadly lymphoma

A new class of drugs that inhibits a 'master switch' involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

Diseases, Conditions, Syndromes

Computer-aided drug design added to global fight against COVID-19

Life sciences company UCB is the first pharma company to join the COVID Moonshot crowdsourcing initiative, which involves the Diamond Light Source synchrotron facility in Oxfordshire and the Weizmann Institute of Science ...

Medical research

New killing mechanism discovered in 'game-changing' antibiotic

Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin—a new class of potent natural antibiotic capable of killing ...

Medical research

Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder cancer in laboratory rats. Later, research revealed that these findings were not relevant ...

page 2 from 7